Quality Control Authority

Quality Control Authority

Quality control compliance operates at the intersection of regulatory obligation and operational discipline, governing how organizations demonstrate that products and processes meet defined requirements. This page covers the foundational structure of compliance standards — what they are, how they function within quality systems, and where the boundaries between voluntary and mandatory frameworks fall. Understanding these distinctions is essential for manufacturers, suppliers, and regulated entities subject to federal agency oversight or third-party certification requirements.

Definition and scope

Compliance standards in quality control are documented specifications, criteria, or procedural requirements that an organization must satisfy to operate lawfully, achieve certification, or pass third-party verification. They are not uniform in legal weight. Standards fall into two primary categories:

• Mandatory/regulatory standards — requirements established by law or federal agency rulemaking, violation of which carries enforceable penalties. Examples include FDA's Quality System Regulation (21 CFR Part 820) for medical devices and OSHA's process safety management standard (29 CFR 1910.119).

• Voluntary/consensus standards — specifications developed by recognized standards bodies such as the American National Standards Institute (ANSI), ASTM International, or the International Organization for Standardization (ISO). Organizations adopt these by choice, by contractual obligation, or as a pathway to market access.

The scope of a given standard is bounded by product type, industry sector, and jurisdiction. ISO 9001, published by ISO and available through ANSI, establishes a general quality management system framework applicable across industries. ISO 13485 applies specifically to medical device manufacturers. These two standards share structural DNA — both use a process-based approach and require documented procedures — but ISO 13485 imposes stricter design control and post-market surveillance requirements that align with regulatory expectations from agencies like the FDA.

The distinction between the two categories is operationally critical. A manufacturer might achieve ISO 9001 certification without satisfying FDA regulatory requirements; the reverse is also true. See Quality Control Compliance Requirements for a sector-by-sector breakdown of which frameworks apply to specific industries.

How it works

Compliance frameworks function through a structured cycle of requirement identification, implementation, verification, and ongoing maintenance. The core mechanism involves four discrete phases:

• Requirement identification — Determine which standards and regulations apply based on product classification, market, and customer contracts. A Class II medical device entering the US market triggers 21 CFR Part 820 and typically ISO 13485 alignment. An industrial fastener manufacturer supplying aerospace customers may be required to meet AS9100 (published by SAE International) alongside customer-specific source control drawings.

• Gap analysis and implementation — Compare existing quality system documentation, processes, and records against the identified requirements. Gaps are logged and addressed through documented corrective actions. The process framework for compliance provides structured methodology for this phase.

• Verification and audit — Regulatory inspections, internal audits, and third-party certification audits confirm that documented procedures match actual practice. The FDA's Center for Devices and Radiological Health (CDRH) conducts facility inspections using the Quality System Inspection Technique (QSIT), a risk-stratified approach that prioritizes higher-risk subsystems such as corrective and preventive action (CAPA) and design controls.

• Maintenance and surveillance — Standards are periodically revised. ISO publishes new editions on a cycle managed by its technical committees; organizations must monitor revision timelines and update their quality management systems accordingly. ISO 9001 underwent a major revision in 2015, shifting to a risk-based thinking model.

NIST publishes supporting frameworks for measurement and calibration compliance, including NIST Handbook 44, which specifies tolerances for commercial weighing and measuring devices used in regulated trade.

Common scenarios

Several situations represent the most frequent compliance decision points in quality-controlled environments:

• New product introduction: A manufacturer entering a regulated market must determine applicable standards before design begins. Waiting until production to identify requirements creates costly retroactive redesign and documentation burdens.

• Supplier qualification: Purchasing organizations require suppliers to demonstrate compliance with specific standards — often AS9100, ISO 9001, or IATF 16949 (automotive) — as a condition of approved supplier status. Supplier non-compliance can trigger incoming inspection holds and supply chain disruptions.

• Regulatory inspection response: An FDA Warning Letter or a notified body's major nonconformance finding requires documented corrective action within defined timeframes. Failure to close findings within the agency's specified period can result in import alerts or certification suspension.

• Standard revision transitions: When ISO 9001 moved from the 2008 version to the 2015 edition, certified organizations had a 3-year transition window (ending September 2018) to update their quality management systems. Organizations that missed this window lost certification status.

• Multi-standard environments: A pharmaceutical manufacturer supplying to both US and EU markets must reconcile FDA's Current Good Manufacturing Practice (cGMP) regulations (21 CFR Parts 210–211) with EU GMP guidelines published by the European Medicines Agency (EMA). Harmonization efforts under the International Council for Harmonisation (ICH) reduce — but do not eliminate — dual-system burdens.

Decision boundaries

Determining which standard applies and at what threshold requires evaluating three factors: regulatory jurisdiction, product classification, and customer contractual requirements.

Regulatory jurisdiction is non-negotiable. A US-marketed device subject to FDA jurisdiction must comply with 21 CFR Part 820 regardless of any voluntary certification status. Voluntary certification to ISO 13485 does not substitute for FDA compliance, though FDA has recognized the alignment between the two frameworks in its Medical Device Single Audit Program (MDSAP).

Product classification determines the stringency tier. FDA classifies medical devices into Class I, II, and III — with Class III devices subject to premarket approval and the most rigorous quality system controls. Class I devices may qualify for general controls only, exempting them from some design control requirements.

Contractual requirements can elevate obligations beyond the regulatory baseline. An aerospace prime contractor may require AS9100 Rev D certification and first-article inspection per AS9102 from all direct suppliers, irrespective of federal regulatory mandates.

When a conflict exists between a voluntary standard and a regulatory requirement, the regulatory requirement prevails. Where standards are silent on a topic, risk-based quality compliance methodology — aligned with ISO 31000 and FDA's own guidance on risk management — provides the decision logic for determining adequate controls.

This site is part of the Trade Services Authority network.

Read Next

Quality Control Compliance Requirements ANA › Life Services Authority › Quality Control Authority Quality Control Compliance Requirements Quality control... Process Framework for Compliance ANA › Life Services Authority › Quality Control Authority Process Framework for Compliance A process framework for... Risk-Based Quality Compliance ANA › Life Services Authority › Quality Control Authority Risk-Based Quality Compliance Risk-based quality compliance...